All results
2 results
-
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis (20210052)
In general, what is the purpose of the research, how long will you be involved? You are being asked to be in this research study because you have idiopathic…
- Ages
- 40 Years - 99 Years
- Sexes
- All
-
An Open-label Extension Study of Inhaled Treprostinil in Subjects with Fibrotic Lung Disease (20212063)
This study is investigating long-term treatment with a drug called inhaled treprostinil (brand name Tyvaso®) in people with Idiopathic Pulmonary Fibrosis…
- Ages
- 40 Years - 99 Years
- Sexes
- All